Skip to content

Utah Medical Products UTMD Accrued liabilities

Accrued liabilities at other companies

UFP Technologies logo
UFP TechnologiesUFPT
-$2.53M-31.5%
Medline, Inc.
 logo
Medline, Inc. MDLN
$72M+112%
CorMedix logo
CorMedixCRMD
-$50.62M-15,373%
Avanos Medical logo
Avanos MedicalAVNS
-$33.7M-128%
Merit Medical Systems logo
Merit Medical SystemsMMSI

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity
Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's accrued liabilities?
Utah Medical Products (UTMD) reported accrued liabilities of $627K in Q1 2026.
How has Utah Medical Products's accrued liabilities changed year-over-year?
Utah Medical Products's accrued liabilities increased by 74.2% year-over-year, from $360K to $627K.
What does accrued liabilities mean?
Tracks the net change in expenses that have been incurred but not yet paid, such as wages or taxes. Fluctuations in this balance provide insight into the company's short-term operational obligations and the timing of cash disbursements.